Luo Tong Formula Alleviates Diabetic Retinopathy in Rats Through Micro-200b Target.

Pang, Bing; Ni, Qing; Di, Sha; Du, Li-Juan; Qin, Ya-Li; Li, Qing-Wei; Li, Min; Tong, Xiao-Lin

Pang, Bing; Ni, Qing; Di, Sha; Du, Li-Juan; Qin, Ya-Li; Li, Qing-Wei; Li, Min; Tong, Xiao-Lin.

Afiliação

Pang B; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Ni Q; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Di S; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Du LJ; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Qin YL; Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Li QW; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Li M; Molecular Biology Laboratory, Guang' Anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Tong XL; Department of Endocrinology, Guang' Anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Front Pharmacol ; 11: 551766, 2020.

Article em En | MEDLINE | ID: mdl-33324202

Palavras-chave

diabetic retinopathy; luo tong formula; microrna-200b; prevention; vascular endothelial growth factor/pigment epithelium-derived factor ratio

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google